This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Clinton Group Calls On Xenoport To Hold Annual Elections For All Directors

NEW YORK, Dec. 16, 2013 /PRNewswire/ -- Clinton Group, Inc. ("Clinton Group"), one of the largest owners of Xenoport, Inc. (NASDAQ: XNPT) ("Xenoport"), sent a letter to the Lead Director of Xenoport, Dr. John G. Freund, following a recent meeting with Dr. Freund and Dennis Fenton, another independent director of Xenoport.

In the meeting, the Clinton Group reiterated its view that Xenoport should be solely focused on the development of its novel fumaric acid ester compound (known as "829"), which the Clinton Group believes has the prospect of being a blockbuster drug with a relatively low risk development path. While the directors defended the current capital allocation approach – and the test marketing of gabapentin enacarbil in 40 US markets – they also expressed recognition that the shareholders own Xenoport and that the Chief Executive Officer and directors should be held accountable.

In the meeting, and again in today's letter, the Clinton Group called upon the directors to allow shareholders to vote on each of the directors each year, as is the practice at a majority of public companies in the United States, starting in 2014.

"Xenoport's stock is down more than 35% this year while the Nasdaq Biotechnology Index has soared more than 50%," said Gregory P. Taxin, President of Clinton Group. "And yet, Xenoport may well have one of the most clinically and commercially significant compounds in its labs. We believe shareholders are unhappy that Xenoport has not exclusively focused on 829 and fear further dilution in their ownership of 829 because of the decisions of the Chief Executive and the Board. While we appreciate that the directors expressed a willingness to be held accountable to shareholders, Xenoport's charter protects the Board from real accountability by giving each director a three-year term. These directors have the power to change that. We call upon the directors to put themselves (and their strategy, decisions and track record) on the ballot in 2014, so shareholders can have an up-or-down vote on this Board's stewardship."

The Clinton Group believes that the best path forward for Xenoport is to hire a new, accomplished Chief Executive who will act like an owner and focus entirely on the development of 829. The Clinton Group would support the current Board at the 2014 Annual Meeting of Shareholders if the directors move swiftly to identify and hire such a Chief Executive and focus the Company's efforts on 829.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs